Literature DB >> 22099877

β1 integrin is required for anchorage-independent growth and invasion of tumor cells in a context dependent manner.

Allana M Schooley1, Natalie M Andrews, Huijun Zhao, Christina L Addison.   

Abstract

Recent studies suggest that extracellular matrix (ECM) components within the tumor microenvironment can influence malignant progression, thus we investigated the influence of the ECM binding receptor β1 integrin, on the hallmark properties of tumorigenesis. Small interfering (si) or short hairpin (sh) RNA approaches were used to deplete β1 integrin in cancer cell lines. β1 integrin-depleted cells were then assessed for their growth and invasive capabilities using 2-dimensional (2D) or 3D culture conditions. Depletion of β1 integrin expression did not impact cell growth in 2D assay systems; however, β1 integrin and its ligand fibronectin were required for growth in 3D. β1 integrin-depleted cells also had reduced invasive capabilities, in part due to increased tissue inhibitor of metalloprotease (TIMP)-2 expression in conjunction with down-regulation of matrix metalloprotease (MMP)-9 levels in β1 integrin-depleted cells. Our results suggest that despite no apparent effect on 2D cell growth, fibronectin-β1 integrin signaling is a critical mediator of the 3D growth and invasive properties of tumor cells. These observations highlight the importance of investigating the role of adhesion molecules in the appropriate context and furthermore identify β1 integrin as a possible therapeutic target to inhibit the aggressive growth and invasion of tumor cells.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22099877     DOI: 10.1016/j.canlet.2011.10.032

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Multifunctional bioscaffolds for 3D culture of melanoma cells reveal increased MMP activity and migration with BRAF kinase inhibition.

Authors:  Jennifer L Leight; Emi Y Tokuda; Caitlin E Jones; Austin J Lin; Kristi S Anseth
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

2.  Expression of ITGB1 predicts prognosis in colorectal cancer: a large prospective study based on tissue microarray.

Authors:  Qi-Zhi Liu; Xian-Hua Gao; Wen-Jun Chang; Hai-Feng Gong; Chuan-Gang Fu; Wei Zhang; Guang-Wen Cao
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 3.  Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance.

Authors:  Laetitia Seguin; Jay S Desgrosellier; Sara M Weis; David A Cheresh
Journal:  Trends Cell Biol       Date:  2015-01-05       Impact factor: 20.808

4.  β1 integrin: an emerging player in the modulation of tumorigenesis and response to therapy.

Authors:  Grant A Howe; Christina L Addison
Journal:  Cell Adh Migr       Date:  2012-03-01       Impact factor: 3.405

5.  Insulin-like growth factor binding protein-3 inhibits cell adhesion via suppression of integrin β4 expression.

Authors:  Hyo-Jong Lee; Ji-Sun Lee; Su Jung Hwang; Ho-Young Lee
Journal:  Oncotarget       Date:  2015-06-20

6.  MiR-183 Regulates ITGB1P Expression and Promotes Invasion of Endometrial Stromal Cells.

Authors:  Jie Chen; Lin Gu; Jie Ni; Ping Hu; Kai Hu; Ying-Li Shi
Journal:  Biomed Res Int       Date:  2015-08-19       Impact factor: 3.411

7.  In vivo effects of olive oil and trans-fatty acids on miR-134, miR-132, miR-124-1, miR-9-3 and mTORC1 gene expression in a DMBA-treated mouse model.

Authors:  Richard Molnar; Laszlo Szabo; Andras Tomesz; Arpad Deutsch; Richard Darago; Nowrasteh Ghodratollah; Timea Varjas; Balazs Nemeth; Ferenc Budan; Istvan Kiss
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

Review 8.  Updates on mechanistic insights and targeting of tumour metastasis.

Authors:  Zeru Feng; Qiuxuan Yu; Ting Zhang; Wanpeng Tie; Jing Li; Xikun Zhou
Journal:  J Cell Mol Med       Date:  2020-01-19       Impact factor: 5.310

9.  Rab13 regulates sEV secretion in mutant KRAS colorectal cancer cells.

Authors:  Scott A Hinger; Jessica J Abner; Jeffrey L Franklin; Dennis K Jeppesen; Robert J Coffey; James G Patton
Journal:  Sci Rep       Date:  2020-09-25       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.